Sun Pharma receives DCGI approval to launch generic semaglutide injection, Noveltreat, for weight management in India.
The company has received approval from the Drugs Controller General of India (DCGI) to manufacture and market Semaglutide ...
Tough one to swallow. The post X’s Head of Product One Shotted by Errant Piece of Fried Chicken appeared first on Futurism.
Sun Pharmaceutical Industries announced that it has received approval from the Drugs Controller General of India (DCGI) to manufacture and market a generic version of semaglutide injection.
The Chosun Ilbo on MSN
US bio firms develop single-injection gene therapies to cure obesity
Recent GLP-1 (glucagon-like peptide-1) obesity treatments such as ‘Wegovy’ and ‘Mounjaro’ have gained immense popularity, but ...
Live Science on MSN
Wegovy now comes in pill form — here's how it works
The pill version of Wegovy seems to work just as well as the injectable form, but there are some key differences between the ...
Sun Pharmaceutical Industries has received approval from the Drugs Controller General of India (DCGI) to manufacture and ...
Accepting the toxicity data submitted by Macleods Pharmaceuticals, the Subject Expert Committee (SEC) functioning under the ...
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated for weight management as an adjunct to a reduced-calorie diet and increased physical activity.
Montreal Gazette on MSNOpinion
The Right Chemistry: Ripples of discovery created a new wave of weight-loss medications
When it comes to pharmacology, the big story these days is the development of the “glucagon-like peptide-1 (GLP-1) mimics,” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results